Computers have become essential tools in pharmaceutical research and development over the past several decades. Early uses of computers focused on relating chemical structures to biological properties through quantitative structure-activity relationship analysis. Advances in computer hardware, software, and databases in the 1980s-1990s enabled more sophisticated computational modeling and analysis. Widespread adoption of personal computers and user-friendly interfaces helped integrate computational methods among medicinal chemists. Today, supercomputers and advanced modeling allow high-throughput virtual screening to rapidly identify potential drug candidates.
Computers in pharmaceutical research and development, General overview, Brief...Manikant Prasad Shah
This document discusses the history of computers in pharmaceutical research and development. It describes how computers first began to be used in the 1940s and the early pioneers in computational chemistry in the 1950s and 1960s. It outlines the advancements made in the field in the following decades, including the development of quantum chemistry models, molecular mechanics, and other approaches. The document emphasizes that computational chemistry experts now play an important role in drug discovery by maximizing the benefits of computer technologies.
In this presentation I have mentioned whatever the possible relevant content required for the title.
Citation Is done at the end of slide.
Content is up to date & true to my belief.
Thanks & Best Regards.
Anurag Pandey
B.Pharm (FACULTY OF PHARMACY, INVERTIS UNIVERSITY)
M.Pharm (INSTITUTE OF PHARMACY, NIRMA UNIVERSITY)
Email :- anurag.dmk05@gmail.com
This document discusses descriptive versus mechanistic modelling in the pharmaceutical industry. Descriptive models are used to describe data without understanding the underlying mechanism, while mechanistic models attempt to understand the data-generating process. Examples are provided of using non-parametric techniques like kernel regression for descriptive modelling and differential equation models for mechanistic modelling of tumor growth curves. The conclusion emphasizes that mechanistic models going beyond simple data fitting to incorporate scientific knowledge can help justify models and improve understanding of biological processes.
History of computers in pharmaceutical research and developmentZahid1392
Computers have been used in pharmaceutical research since the 1940s, starting with early machines like the IBM 650. Over subsequent decades, computational approaches like quantum chemistry, molecular mechanics, molecular simulations, and QSAR grew alongside increasing computer power. The 1980s saw many of these approaches combine into modern computational chemistry. By the 1990s, computer-based drug discovery was yielding new drugs, as workstations and supercomputers assisted research. Computational chemistry experts now play an important role in pharmaceutical research and development.
Statistical modeling in Pharmaceutical research and development.pptxPawanDhamala1
The document discusses statistical modeling in pharmaceutical research and development. It begins with definitions of statistics and pharmaceutical statistics. It then discusses the history and concepts of statistical modeling, noting that models help reduce drug development costs and time while improving quality. Models can be descriptive, modeling real-world events, or mechanistic, based on natural science principles. The objective of models is to improve understanding of experiments and drugs through representation of reality.
Computer simulations in pharmacokinetics and pharmacodynamicsGOKULAKRISHNAN S
This document discusses computer simulations in pharmacokinetics and pharmacodynamics. It describes how whole organism, isolated tissue, and organ simulations work. For whole organism simulations, two approaches are used: lumped-parameter PK-PD modeling which uses differential equations to model the system over time, and physiological modeling which attempts to model interacting organs in detail. Isolated tissue and organ simulations are also discussed, focusing on models of the heart, liver, kidney and brain. The challenges of complexity and model selection are addressed.
Computers in pharmaceutical research and development, General overview, Brief...Manikant Prasad Shah
This document discusses the history of computers in pharmaceutical research and development. It describes how computers first began to be used in the 1940s and the early pioneers in computational chemistry in the 1950s and 1960s. It outlines the advancements made in the field in the following decades, including the development of quantum chemistry models, molecular mechanics, and other approaches. The document emphasizes that computational chemistry experts now play an important role in drug discovery by maximizing the benefits of computer technologies.
In this presentation I have mentioned whatever the possible relevant content required for the title.
Citation Is done at the end of slide.
Content is up to date & true to my belief.
Thanks & Best Regards.
Anurag Pandey
B.Pharm (FACULTY OF PHARMACY, INVERTIS UNIVERSITY)
M.Pharm (INSTITUTE OF PHARMACY, NIRMA UNIVERSITY)
Email :- anurag.dmk05@gmail.com
This document discusses descriptive versus mechanistic modelling in the pharmaceutical industry. Descriptive models are used to describe data without understanding the underlying mechanism, while mechanistic models attempt to understand the data-generating process. Examples are provided of using non-parametric techniques like kernel regression for descriptive modelling and differential equation models for mechanistic modelling of tumor growth curves. The conclusion emphasizes that mechanistic models going beyond simple data fitting to incorporate scientific knowledge can help justify models and improve understanding of biological processes.
History of computers in pharmaceutical research and developmentZahid1392
Computers have been used in pharmaceutical research since the 1940s, starting with early machines like the IBM 650. Over subsequent decades, computational approaches like quantum chemistry, molecular mechanics, molecular simulations, and QSAR grew alongside increasing computer power. The 1980s saw many of these approaches combine into modern computational chemistry. By the 1990s, computer-based drug discovery was yielding new drugs, as workstations and supercomputers assisted research. Computational chemistry experts now play an important role in pharmaceutical research and development.
Statistical modeling in Pharmaceutical research and development.pptxPawanDhamala1
The document discusses statistical modeling in pharmaceutical research and development. It begins with definitions of statistics and pharmaceutical statistics. It then discusses the history and concepts of statistical modeling, noting that models help reduce drug development costs and time while improving quality. Models can be descriptive, modeling real-world events, or mechanistic, based on natural science principles. The objective of models is to improve understanding of experiments and drugs through representation of reality.
Computer simulations in pharmacokinetics and pharmacodynamicsGOKULAKRISHNAN S
This document discusses computer simulations in pharmacokinetics and pharmacodynamics. It describes how whole organism, isolated tissue, and organ simulations work. For whole organism simulations, two approaches are used: lumped-parameter PK-PD modeling which uses differential equations to model the system over time, and physiological modeling which attempts to model interacting organs in detail. Isolated tissue and organ simulations are also discussed, focusing on models of the heart, liver, kidney and brain. The challenges of complexity and model selection are addressed.
The document discusses nose-to-brain drug delivery systems, which transport drugs through the nasal route to the central nervous system. It bypasses the blood-brain barrier by passing through the olfactory nerve and trigeminal nerve pathways. This provides a non-invasive method for targeted delivery of drugs to the central nervous system with reduced systemic side effects. The document outlines the advantages, limitations, nasal structure and mechanisms, factors affecting absorption, and formulation strategies for nose-to-brain drug delivery.
DESCRIPTIVE VERSUS MECHANISTIC MODELING ppt..pptxPawanDhamala1
The document discusses descriptive versus mechanistic modeling approaches. Descriptive models describe overall system behavior without claiming to represent underlying mechanisms, while mechanistic models directly correspond to real system components and interactions. Key differences are that descriptive models are empirical and incremental, while mechanistic models have tangible system representations but can be challenging due to nonlinearity and noise. The objectives of modeling are reducing drug discovery costs and times through experiment iteration and model improvement.
The document discusses various topics related to drug dissolution testing and absorption:
1. It describes 7 common dissolution apparatus used for testing according to the USP and provides details on rotating basket (Apparatus 1) and paddle (Apparatus 2) methods.
2. It explains the levels of correlation (A, B, C) between in vitro dissolution data and in vivo drug absorption, with Level A being a point-to-point correlation and the highest level.
3. It introduces concepts like the permeability-solubility-charge state model and pH partition hypothesis which aim to understand efficient drug permeation across membranes based on factors like solubility and ionization state.
Optimal design & Population mod pyn.pptxPawanDhamala1
This document discusses optimal design and population modeling. It begins with an introduction to optimal design, noting that it allows parameters to be estimated without bias and with minimum variance. The advantages of optimal design are that it reduces experimentation costs by allowing statistical models to be estimated with fewer runs. It then describes different types of optimal designs such as A, C, D, and E optimality. The document next discusses population modeling, explaining that it is a tool for integrating data to aid drug development decisions. It notes the key components of population models are structural models, stochastic models, and covariate models. Structural models describe the response over time using algebraic or differential equations, while stochastic models describe variability and covariate models influence factors like dem
computer aided formulation developmentSUJITHA MARY
The document discusses optimization techniques used in computer aided formulation development. It defines optimization as choosing the best alternative while considering all influencing factors. Optimization techniques help minimize experimental trials, reduce costs and save time compared to traditional trial and error methods. The document describes various experimental design approaches like factorial designs, response surface methodology and mixture designs that are used to optimize formulations. It also discusses simultaneous techniques like evolutionary operations and simplex method as well as sequential techniques like mathematical modeling and search methods. Optimization is important for developing formulations with desired performance and ensuring reproducible, large-scale manufacturing.
hisory of computers in pharmaceutical research presentation.pptxDhanaa Dhoni
Computers have been used in pharmaceutical research and development since the 1940s. Early computers were large mainframe systems that were expensive and shared between organizations. By the 1960s, some pharmaceutical companies had acquired early computers like the IBM 650 to assist with scientific tasks. Today, computers are essential for tasks across the pharmaceutical industry from drug design and clinical trials to manufacturing, sales, and more. Advanced statistical modeling and software continue to be important tools in pharmaceutical research and development.
This document discusses the use of computers in pharmaceutical formulation. It begins with an introduction to pharmaceutical formulation and design of experiment techniques. It then provides examples of emulsion and microemulsion formulations. The document reviews several software programs used for design of experiment and optimization in formulation development. It also discusses using design of experiment techniques for screening critical factors and developing different dosage forms. Finally, it covers legal protection of innovative computer uses in research and development, including patents, copyright, database protection, and trade secrets.
Statistical modeling in pharmaceutical research and developmentPV. Viji
Statistical modeling in pharmaceutical research and development , Statistical Modeling , Descriptive Versus Mechanistic Modeling , Statistical Parameters Estimation , Confidence Regions , Non Linearity at the Optimum , Sensitivity Analysis , Optimal Design , Population Modeling
This document discusses various compendial methods for drug dissolution testing. It begins by defining dissolution as the process where a solid substance solubilizes in a solvent, transferring mass from the solid surface to the liquid phase. It then describes the seven USP dissolution apparatus types and their applications for testing different drug products like tablets, capsules, modified release formulations and transdermal systems. The document provides details on factors that influence dissolution test design and the principles of operation for each apparatus type.
Statistical modeling in pharmaceutical research and development.ANJALI
Statistical modeling in pharmaceutical research and development. This modelling is used in pharmaceutical industries to overcome the challenges related to pharmaceutical formulation, to reduce cost and increase quality and speed of pharmaceutical products.
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...PRAJAKTASAWANT33
Introduction, biopharmaceutic factors affecting drug bioavailability, rate–limiting steps in drug absorption, physicochemical nature of the drug formulation factors affecting drug product performance
The document discusses several key concepts related to drug transport and absorption:
1) The pH partition hypothesis states that acidic drugs are absorbed from acidic solutions and basic drugs from alkaline solutions, though some exceptions exist due to the microclimate pH near the membrane surface.
2) Tight junctions form a virtually impermeable barrier between cells, composed of sealing strands that prevent fluid passage.
3) According to Fick's first law, passive diffusion of solutes is determined by concentration gradients and membrane permeability. For ionizable drugs, the uncharged form is more permeable. The pH partition hypothesis relates permeability to pH and the fraction of uncharged molecules.
This document discusses descriptive versus mechanistic modeling approaches in drug discovery. It provides examples of descriptive modeling, which aims to describe data patterns without understanding the underlying mechanisms, and mechanistic modeling, which works with domain experts to translate scientific knowledge into mathematical representations of the data-generating processes. The document presents tumor growth curve analysis as an example where mechanistic models like Richards and Gompertz curves can incorporate understandings of competing catabolic and anabolic processes to better capture the fundamental characteristics of growth.
Computational modelling of drug disposition lalitajoshi9
computational modelling of drug disposition is the integral part of computer aided drug design. different kinds of tools being used in the prediction of drug disposition in human body. This topic in the CADD explains the details about the drug disposition, active transporters and tools.
This document presents a summary of gastrointestinal (GI) simulation and model construction for predicting oral drug absorption. It discusses various compartmental models that can be used for GI simulation, including CAT, ADAM, Grass, and GITA models. Commercial software packages for GI simulation are also listed, such as GastroPlus, INTELLIPHARM PKCR, SimCYP, PK-Sim, IDEA, Cloe PK, and Cloe HIA. The document then focuses on using GastroPlus software to construct two models to simulate the oral absorption of the drug Nimesulide and compare the predicted pharmacokinetic parameters to observed in vivo data. Model 2 provided a better fit to the in vivo observations by accounting
Computers have played an increasingly important role in pharmaceutical research and development since the 1940s. Early computers were limited in capabilities but allowed for some basic calculations. By the 1960s-1970s, computational approaches like QSAR began to be used, though medicinal chemists were initially skeptical. Advances in hardware and software through the 1980s-1990s made computational methods more practical and useful for drug discovery. Today, computational tools are indispensable for assisting medicinal chemists at various stages of the drug development process.
Computers have played an increasingly important role in pharmaceutical research and development since the 1940s. Early uses involved accounting and basic calculations, but over the decades computational approaches became more sophisticated and were applied to areas like molecular modeling, drug design, data management, and analysis. By the 1990s, computational methods had become fully integrated into the drug discovery process and essential for efficiently generating and evaluating large numbers of potential drug candidates. Today, computers continue to transform pharmaceutical R&D through applications such as 3D printing, personalized medicine, and advanced data analytics.
The document discusses nose-to-brain drug delivery systems, which transport drugs through the nasal route to the central nervous system. It bypasses the blood-brain barrier by passing through the olfactory nerve and trigeminal nerve pathways. This provides a non-invasive method for targeted delivery of drugs to the central nervous system with reduced systemic side effects. The document outlines the advantages, limitations, nasal structure and mechanisms, factors affecting absorption, and formulation strategies for nose-to-brain drug delivery.
DESCRIPTIVE VERSUS MECHANISTIC MODELING ppt..pptxPawanDhamala1
The document discusses descriptive versus mechanistic modeling approaches. Descriptive models describe overall system behavior without claiming to represent underlying mechanisms, while mechanistic models directly correspond to real system components and interactions. Key differences are that descriptive models are empirical and incremental, while mechanistic models have tangible system representations but can be challenging due to nonlinearity and noise. The objectives of modeling are reducing drug discovery costs and times through experiment iteration and model improvement.
The document discusses various topics related to drug dissolution testing and absorption:
1. It describes 7 common dissolution apparatus used for testing according to the USP and provides details on rotating basket (Apparatus 1) and paddle (Apparatus 2) methods.
2. It explains the levels of correlation (A, B, C) between in vitro dissolution data and in vivo drug absorption, with Level A being a point-to-point correlation and the highest level.
3. It introduces concepts like the permeability-solubility-charge state model and pH partition hypothesis which aim to understand efficient drug permeation across membranes based on factors like solubility and ionization state.
Optimal design & Population mod pyn.pptxPawanDhamala1
This document discusses optimal design and population modeling. It begins with an introduction to optimal design, noting that it allows parameters to be estimated without bias and with minimum variance. The advantages of optimal design are that it reduces experimentation costs by allowing statistical models to be estimated with fewer runs. It then describes different types of optimal designs such as A, C, D, and E optimality. The document next discusses population modeling, explaining that it is a tool for integrating data to aid drug development decisions. It notes the key components of population models are structural models, stochastic models, and covariate models. Structural models describe the response over time using algebraic or differential equations, while stochastic models describe variability and covariate models influence factors like dem
computer aided formulation developmentSUJITHA MARY
The document discusses optimization techniques used in computer aided formulation development. It defines optimization as choosing the best alternative while considering all influencing factors. Optimization techniques help minimize experimental trials, reduce costs and save time compared to traditional trial and error methods. The document describes various experimental design approaches like factorial designs, response surface methodology and mixture designs that are used to optimize formulations. It also discusses simultaneous techniques like evolutionary operations and simplex method as well as sequential techniques like mathematical modeling and search methods. Optimization is important for developing formulations with desired performance and ensuring reproducible, large-scale manufacturing.
hisory of computers in pharmaceutical research presentation.pptxDhanaa Dhoni
Computers have been used in pharmaceutical research and development since the 1940s. Early computers were large mainframe systems that were expensive and shared between organizations. By the 1960s, some pharmaceutical companies had acquired early computers like the IBM 650 to assist with scientific tasks. Today, computers are essential for tasks across the pharmaceutical industry from drug design and clinical trials to manufacturing, sales, and more. Advanced statistical modeling and software continue to be important tools in pharmaceutical research and development.
This document discusses the use of computers in pharmaceutical formulation. It begins with an introduction to pharmaceutical formulation and design of experiment techniques. It then provides examples of emulsion and microemulsion formulations. The document reviews several software programs used for design of experiment and optimization in formulation development. It also discusses using design of experiment techniques for screening critical factors and developing different dosage forms. Finally, it covers legal protection of innovative computer uses in research and development, including patents, copyright, database protection, and trade secrets.
Statistical modeling in pharmaceutical research and developmentPV. Viji
Statistical modeling in pharmaceutical research and development , Statistical Modeling , Descriptive Versus Mechanistic Modeling , Statistical Parameters Estimation , Confidence Regions , Non Linearity at the Optimum , Sensitivity Analysis , Optimal Design , Population Modeling
This document discusses various compendial methods for drug dissolution testing. It begins by defining dissolution as the process where a solid substance solubilizes in a solvent, transferring mass from the solid surface to the liquid phase. It then describes the seven USP dissolution apparatus types and their applications for testing different drug products like tablets, capsules, modified release formulations and transdermal systems. The document provides details on factors that influence dissolution test design and the principles of operation for each apparatus type.
Statistical modeling in pharmaceutical research and development.ANJALI
Statistical modeling in pharmaceutical research and development. This modelling is used in pharmaceutical industries to overcome the challenges related to pharmaceutical formulation, to reduce cost and increase quality and speed of pharmaceutical products.
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...PRAJAKTASAWANT33
Introduction, biopharmaceutic factors affecting drug bioavailability, rate–limiting steps in drug absorption, physicochemical nature of the drug formulation factors affecting drug product performance
The document discusses several key concepts related to drug transport and absorption:
1) The pH partition hypothesis states that acidic drugs are absorbed from acidic solutions and basic drugs from alkaline solutions, though some exceptions exist due to the microclimate pH near the membrane surface.
2) Tight junctions form a virtually impermeable barrier between cells, composed of sealing strands that prevent fluid passage.
3) According to Fick's first law, passive diffusion of solutes is determined by concentration gradients and membrane permeability. For ionizable drugs, the uncharged form is more permeable. The pH partition hypothesis relates permeability to pH and the fraction of uncharged molecules.
This document discusses descriptive versus mechanistic modeling approaches in drug discovery. It provides examples of descriptive modeling, which aims to describe data patterns without understanding the underlying mechanisms, and mechanistic modeling, which works with domain experts to translate scientific knowledge into mathematical representations of the data-generating processes. The document presents tumor growth curve analysis as an example where mechanistic models like Richards and Gompertz curves can incorporate understandings of competing catabolic and anabolic processes to better capture the fundamental characteristics of growth.
Computational modelling of drug disposition lalitajoshi9
computational modelling of drug disposition is the integral part of computer aided drug design. different kinds of tools being used in the prediction of drug disposition in human body. This topic in the CADD explains the details about the drug disposition, active transporters and tools.
This document presents a summary of gastrointestinal (GI) simulation and model construction for predicting oral drug absorption. It discusses various compartmental models that can be used for GI simulation, including CAT, ADAM, Grass, and GITA models. Commercial software packages for GI simulation are also listed, such as GastroPlus, INTELLIPHARM PKCR, SimCYP, PK-Sim, IDEA, Cloe PK, and Cloe HIA. The document then focuses on using GastroPlus software to construct two models to simulate the oral absorption of the drug Nimesulide and compare the predicted pharmacokinetic parameters to observed in vivo data. Model 2 provided a better fit to the in vivo observations by accounting
Computers have played an increasingly important role in pharmaceutical research and development since the 1940s. Early computers were limited in capabilities but allowed for some basic calculations. By the 1960s-1970s, computational approaches like QSAR began to be used, though medicinal chemists were initially skeptical. Advances in hardware and software through the 1980s-1990s made computational methods more practical and useful for drug discovery. Today, computational tools are indispensable for assisting medicinal chemists at various stages of the drug development process.
Computers have played an increasingly important role in pharmaceutical research and development since the 1940s. Early uses involved accounting and basic calculations, but over the decades computational approaches became more sophisticated and were applied to areas like molecular modeling, drug design, data management, and analysis. By the 1990s, computational methods had become fully integrated into the drug discovery process and essential for efficiently generating and evaluating large numbers of potential drug candidates. Today, computers continue to transform pharmaceutical R&D through applications such as 3D printing, personalized medicine, and advanced data analytics.
Today, computers are so ubiquitous in pharmaceutical research and development that it may be hard to imagine a time when there were no computers to assist the medicinal chemist or biologist.
A quarter-century ago, the notion of a computer on the desk of every scientist and company manager was noee ven contemplated.
Now, computers are absolutely essential for generating, managing, and transmitting information.
Computers began to be deployed at pharmaceutical companies as early as the 1940.
Chemoinformatics—an introduction for computer scientistsunyil96
Chemoinformatics is an interdisciplinary field that combines expertise from chemistry, biology, physics, and computer science. It aims to discover novel chemical entities that can be developed into new medical treatments. The field uses computational methods and tools to analyze large collections of molecules in order to facilitate drug discovery. This involves tasks like selecting compounds for screening libraries, analyzing results from high-throughput screening to identify hit compounds, and optimizing leads into drug candidates. While the field has existed for decades, it was only recently termed "chemoinformatics" and has grown significantly with the ability to now synthesize and test huge numbers of compounds computationally.
This document discusses the use of computers in pharmaceutical research and development. It begins by explaining how computers have transformed drug development processes by facilitating data storage, online literature searches, and computational modeling approaches. The document then provides a history of computers in pharmaceutical R&D from the 19th century to present day. It describes how early quantitative structure-activity relationship methods laid the groundwork for computer-aided drug design. The document outlines key developments from the 1960s to the 1990s that established computational techniques in major pharmaceutical companies. It distinguishes between descriptive and mechanistic modeling approaches. Finally, it discusses statistical modeling and parameters estimation techniques used in pharmaceutical research.
History of computers in Pharmaceutical research & Developmentsilambarasan I
Computers have been used in pharmaceutical research and development since the 1940s. Early computers in the 1950s-1960s were used for basic calculations and statistical analysis. Advances in computing power and molecular modeling software in the 1960s-1970s allowed for more complex calculations relating chemical structure to biological activity. The 1980s saw further integration of quantum chemistry, molecular mechanics, and molecular graphics into computational chemistry. By the 1990s, workstations and software for molecular modeling were widely used in drug design efforts.
This document discusses cheminformatics, which involves the use of computer software and data analysis to study chemical compounds and their properties. It defines cheminformatics as combining chemical synthesis, biological screening, and data mining for drug discovery. The document outlines the history and evolution of the field from chemical information to cheminformatics. It also discusses various companies involved in cheminformatics and how it applies quantitative structure-activity relationships and other methods to guide drug development.
Cheminformatics (sometimes referred to as chemical informatics or chemoinformatics) focuses on storing, indexing, searching, retrieving, and applying information about chemical compounds. ... Virtual libraries can contain information on likely synthesis methods and predicted stability of the reaction products.
Evolution of Computers in Pharmaceutical Research and Development: A Historic...TariqHusain19
Evolution of Computers in Pharmaceutical Research and Development: A Historical Perspective.
computer aided drug delivery system. use of computer in pharmaceutical
Computers play several important roles in the drug discovery process:
1) They analyze thousands of molecular structures and properties to identify candidate molecules that may bind to disease targets. This virtual screening allows faster evaluation of large libraries.
2) Databases organize data on chemical structures to facilitate computer-aided searches for promising drug candidates.
3) Software allows scientists to visualize and model molecular interactions, guiding the design of molecules that optimally bind to targets.
Pharmaceutical companies use computers in many aspects of the drug discovery process. Computers allow researchers to analyze thousands of molecular structures and rapidly search databases to identify promising drug candidates that can bind to disease targets. They use computational modeling and simulations to predict how well a molecule will bind to and affect its target. This helps streamline the process of discovering and developing new drugs compared to traditional trial-and-error methods. Computers play a key role in expediting tasks from target identification to lead optimization and preclinical testing.
This document discusses cheminformatics, which involves the use of computer software and databases to manage chemical compound data and properties for applications in drug discovery. It defines cheminformatics as combining chemical synthesis, biological screening, and data mining to guide the drug development process. The document outlines the history and evolution of cheminformatics from chemical information to modern applications. It also discusses key companies involved in cheminformatics and related areas like quantitative structure-activity relationships and chemical libraries.
Computational chemistry began in the 1940s when pharmaceutical companies like Lilly first gained access to computers for tasks like accounting and payroll. In the 1960s, as quantum mechanics theories developed, researchers began using computers for molecular modeling and structure determination. The 1970s saw more theoretical chemists hired and programs developed for synthesis planning. Growth continued in the 1980s with advances in software for molecular graphics, modeling, and QSAR analysis. By the 1990s, computational tools were fully integrated into drug discovery with customized programs for various stages of research.
Mobile hardware and software technology continues to evolve very rapidly and presents drug discovery scientists with new platforms for accessing data and performing data analysis. Smartphones and tablet computers can now be used to perform many of the operations previously addressed by laptops or desktop computers. Although the smaller screen sizes and requirements for touch screen manipulation can present user interface design challenges, especially with chemistry related applications, these limitations are driving innovative solutions. In this early review of the topic, we collectively present our diverse experiences as software developer, chemistry database expert and naïve user, in terms of what mobile platforms may provide to the drug discovery chemist in the way of apps in the future as this disruptive technology takes off.
An Introduction to Chemoinformatics for the postgraduate students of AgricultureDevakumar Jain
1. Chemoinformatics is the application of informatics methods to solve chemical problems and encompasses the design, creation, organization, management, retrieval, analysis, dissemination, visualization and use of chemical information.
2. It combines aspects of chemistry and computer science to address challenges such as representing and searching large chemical structure databases, predicting molecular properties, and aiding in drug discovery.
3. Chemoinformatics tools and methods have applications in diverse areas including organic synthesis, analytical chemistry, toxicology prediction, and agrochemical discovery.
Cheminformatics combines chemistry, computer science, and information science to study large amounts of chemical information, mostly with computer assistance. It encompasses the design, creation, organization, storage, retrieval, analysis, and use of chemical data. Cheminformatics has various applications including drug discovery. It uses tools like databases, machine learning, molecular properties predictions, and information analysis to help identify new drug leads. Future trends include increased data integration, computer-assisted synthesis design, and expanded use of cheminformatics methods in theoretical chemistry and protein studies. Cheminformatics plays an important role in modern drug development.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
History of computers in pharmaceutical research & development
1. HISTORY OF COMPUTERS IN
PHARMACEUTICAL RESEARCH &
DEVELOPMENT
SHRI GURU RAM RAI UNIVERSITY
PATELNAGAR, DEHRADUN
PRESENTED BY- ANKIT KUMAR
M.PHARM 1ST YEAR
PHARMACEUTICS
CADD
2. DETAILED OUTLINE ABOUT HISTORY
Today, computers are so ubiquitous in pharmaceutical research and development
that it may be hard to imagine a time when there were no computers to assist the
medicinal chemist or biologist.
A quarter-century ago, the notion of a computer on the desk of every scientist
and company manager was not even contemplated. Now, computers are
absolutely essential for generating, managing, and transmitting information.
The aim of this chapter is to give a brief account of the historical development. It
is a story of ascendancy and one that continues to unfold.
Owing to the personal interest and experience of the authors, the emphasis in this
presentation is on using computers for drug discovery. But the use of computers
in laboratory instruments and for analysis of experimental and clinical data is no
less important.
3. As science advanced scientist began understanding the relation between the chemical
structure of a molecule and its molecular properties including biological activity. On the
basis of molecular properties of any molecule then its structure can be predicted &
investigated in laboratory.
Also at the same time concepts of how a drug exerts its biological activity through binding to
some receptor in the body stemmed from Fischer’s lock and key hypothesis.
“Quantum mechanics” took a leap forward in explaining the movement of electrons in
molecules and how electronic structure impacts biological activity.
In the 1950’s papers began to be published mathematically relating chemical structure to
biological activity. These developments finally led to the introduction to QSAR
(Quantitative Structure Activity Relationships) which basically assigned molecular
descriptors in describing biological activity. These molecular descriptors are nothing but a
calculated or experimental numerical value that describes the chemical structure of that
molecule. QSAR were the result of the engineering development of computers and their use.
Thus the computer, which was initially designed to be used in the military and for accounting
applications, gradually became a tool for scientific innovation.
4. Today computational biology stands at the forefront of innovation and has reduced the time for
finding potential candidates by matching molecular structure databases against target
molecules and finding an appropriate match thus generating a lead compound. With the
advancement in computer technology and faster and more efficient supercomputers like the
“Blue Gene” and “Red Storm” being made, the task is only made simpler.
In the early 1960s drug discovery was by “trial and error”. At that time there were two main
sources of therapeutic compounds. The smaller pipeline was natural products such as plants with
medicinal properties and soil microbes. The major source was classical medicinal chemistry. The
‘chemists at that time manually read literature of products patented by competitors and
used their creativity and expertise to synthesize therapeutically active compounds’. These
compounds would then be tested by in house microbiologists and biochemists. The compounds
were not only tested against its target but also screened for bioactivity against other targets for
which research was being conducted at that time. The most potent compound discovered led to a
series of other structures which were tested hence leading to the creation of a table comparing
the potency and activity, which finally led to one compound that could be effectively called the
drug and after development called a pharmaceutical product. However, these methods involved
time and cost and were inaccurate.
5. Companies such as Abbott, Schering-Plough, Upjohn and
Dow Chemical’s took the initiative to explore using
computers for drug discovery. These initiatives involved
either adding resources with computer proficiency or training
in-house scientists on the new methodology. One of the first
break-through in computational drug discovery was at
Lilly which revealed the relationship between the
calculated electronic structure of beta-lactam ring of
cephalosporins and antibacterial activity. Even though
some of the companies initiated these efforts, some of these
companies lost out as they quit these efforts due to lack of
management support. It was Lilly, whose persistence paid
off as it established its base in such expertise. The
companies at that time invested in hardware and software from
the money they gained from the sale of their products. Widely
used models at that time included the IBM360 and the 370
series and input methods slowly advanced from punch cards to
dumb terminals (terminals or PCs that had no local processing
capability).
6. Software was still written in FORTRAN, followed by the well known MMPI program used
for molecular mechanics. Since molecular mechanics seems to predict the organic chemical
structures more accurately than quantum mechanics (with bond lengths predicted correctly up
to 0.01À), this program was an important development. With these developments the
pharmaceutical industry began transitioning to using molecular mechanics, QSAR and
statistics rather than restricting to quantum mechanics.
• However at the back of all this a war raged between the medicinal and computational
chemists. The computational chemists emphasized that computationally it was easier to
change a nitrogen atom to carbon or any other element or to attach a subsistent at any position
in whatever stereochemistry which would make the compound more active. It was easy to
change a six member ring to a five member ring and so on
7. Lilly took a positive step in this opening communication channels between the two groups and
organized a series of workshops for the medicinal chemists to operate on computational programs
to perform calculations on molecules. This was followed by Merck which conducted a similar
workshop. Despite these initiatives the medicinal chemists were slow to accept what computers
were able to provide. Sometimes they would go to the computational chemists for help with some
of the research computationally like activity listing of a set of compounds and if the computational
methods failed the medicinal chemists would start dismissing the idea of computational chemistry
as a whole.
The truth is that computational techniques should be considered like another apparatus in a lab.
Sometime it would give a positive result, and sometime fail like the rest of the experimental
methods.
In the 1970s two new computer resources were launched namely the Cambridge Structural
Database (CSD) and the PDB (Protein Data Bank). Computational chemists found this as a
boon as these databases would yield more therapeutically active compounds as more compounds
were deposited into them.
The advancement came in the 1980s. The pharmaceutical companies noted the development of
the IBM personal computer (PC), but it had DOS, which made it difficult to use.
8. In 1984, the Apple Macintosh was introduced which set a new standard of user
friendliness to the computer. These machines were great at word processing, graphics
and managing small laboratory databases and suddenly all medicinal chemists took a
liking to it. Also there were advancements on the software front which made most
medicinal chemists enthusiastic about computers. One was the electronic mail. This
saw great advancement in communication and also with this one could easily connect
to other computers and tap into large databases as the cabling and networking
capability advanced.
The second important development was development of certain software like
ChemDraw which allowed chemists to quickly create two dimensional chemical
diagrams which could be cut and pasted into reports, article and patents.
The third important advancement was the ability to view 3D structures of compounds
on a computer screen using either the ball and stick model or space filling
representations of 3D molecular structures and this introduced a whole new field of
“molecular graphics”.
9. On a larger scale pharmaceutical companies started becoming aware of the potential for
computer aided methods of drug design. According to a survey a few years later, 48
chemical and pharmaceutical companies in the US were using computer aided
molecular design methods.
Between 1975 and 1985 the number of computational chemists employed by these
chemists increased from 30 to 150 which were more than doubling every five years.
The 1990s saw the results of the efforts put in the 1980s which yielded a large number
of NCEs (new chemical entities) reaching the pharmaceutical marketplace.
10. “Supercomputers began to appear in the scene too as faster processing and number
crunching became a necessity. Initially no company wanted to make an investment in a
supercomputer and it seems that the market would never break open.”
It was CEO of Cray research who strategically took a bold step of paying a visit to
the CEO of Lilly to offer a supercomputer to the company at an irresistible price. His
strategy paid off, as not only Lilly purchased the supercomputer but other pharmaceutical
companies like Merck, Bristol- Myers Squibb, Marion Merrell Dow, Johnson and Johnson
and Bayer either purchased or leased a supercomputer from Cray research to stay
competitive in the pharmaceutical marketplace.
With computational drug discovery becoming more an more important, the attitude
towards the computational chemists changed, so much so that Lilly and other companies
made computational chemists co-inventors on patents if a computational chemist had
contributed to the discovery.
These factors led to the growth of the computational scientist pool and computers
have become an indispensable factor in the process of drug discovery and
development ever since.